Calendar Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
411.4 USD +0.91% Intraday chart for Vertex Pharmaceuticals Incorporated -0.75% +1.10%

Chart calendar Vertex Pharmaceuticals Incorporated

74e0ee71d5711.bMjOUsjsViWL5LUgloNVtfxRqPuKEQ8DkQFJjG2jasY.BaT_BpqWBW3Cyc9s9OIz_swfwra8JnczoDdx4yCbKLcdvqQbpZgFQ_Gg0g~c52d45e51dd6cb67d877a109a8acdf77

Upcoming events on Vertex Pharmaceuticals Incorporated

2024-04-30 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-10-29 Q3 2024 Earnings Release (Projected)
2025-02-10 Q4 2024 Earnings Release (Projected)

Past events on Vertex Pharmaceuticals Incorporated

2024-03-11 04:00 pm Leerink Partners Global Biopharma Conference
2024-03-05 10:30 am TD Cowen Health Care Conference
2024-02-05 04:30 pm Q4 2023 Earnings Call
2024-02-05 04:01 pm Q4 2023 Earnings Release
2024-01-30 08:00 am VX-548 Phase 3 Study Results Call
2024-01-08 11:15 am JPMorgan Healthcare Conference
2023-12-13 08:00 am VX-548 Phase 2 Study Results Call
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No:4997
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No:4999
2023-12-11 08:00 pm American Society of Hematology Meeting - Abstract Number #1053
2023-12-11 07:45 pm American Society of Hematology Meeting - Abstract Number #1052
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No:3900
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3678
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3674
2023-11-14 03:30 am Jefferies London Healthcare Conference - Fireside Chat
2023-11-09 12:00 pm UBS BioPharma Conference - Fireside Chat
2023-11-06 04:30 pm Q3 2023 Earnings Call
2023-11-06 04:01 pm Q3 2023 Earnings Release
2023-09-13 11:30 am Morgan Stanley Global Healthcare Conference
2023-08-01 04:30 pm Q2 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
4 163
3 759
10.74%
6 206
6 159
0.76%
7 574
7 502
0.97%
8 931
8 933
-0.03%
9 869
9 861
0.08%

10 731

EBITDA
Million USD
Released
Forecast
Spread
1 893
1 770
6.92%
3 601
3 649
-1.33%
4 470
4 490
-0.46%
4 941
5 101
-3.12%
4 556
4 734
-3.75%

5 315

EBIT
Million USD
Released
Forecast
Spread
1 786
1 609
11.02%
3 491
3 471
0.58%
4 344
4 345
-0.02%
4 793
4 832
-0.81%
4 375
4 461
-1.94%

4 967

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
1 395
964
44.64%
3 117
2 891
7.82%
2 730
2 761
-1.12%
4 232
4 155
1.86%
4 380
4 415
-0.8%

4 898

Net income
Million USD
Released
Forecast
Spread
1 177
796
47.91%
2 712
2 608
3.99%
2 342
2 295
2.07%
3 322
3 287
1.06%
3 620
3 574
1.28%

3 895

EPS
USD
Released
Forecast
Spread
4,51
3,08
46.48%
10,3
9,87
4.24%
9,01
8,80
2.4%
12,8
12,8
0.17%
13,9
13,7
1.52%

15,0

Announcement Date30/01/2001/02/2126/01/2207/02/2305/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
2 073
2 007
3.29%
2 098
2 074
1.14%
2 196
2 132
3.03%
2 334
2 227
4.82%
2 303
2 303
-0.01%
2 375
2 336
1.67%
2 493
2 421
3%
2 484
2 502
-0.73%
2 518
2 515
0.12%

2 573


2 655


2 710


2 790


2 690

EBITDA
Million USD
Released
Forecast
Spread





















1 215
1 255
-3.17%
1 210
1 285
-5.81%

1 256


1 277


1 285


1 250




EBIT
Million USD
Released
Forecast
Spread
1 124
1 126
-0.15%
1 167
1 188
-1.82%
1 187
1 179
0.67%
1 289
1 210
6.55%
1 150
1 197
-3.94%
902
971
-7.11%
1 148
1 246
-7.89%
1 173
1 239
-5.32%
1 151
1 237
-6.9%

1 191


1 221


1 240


1 298


1 333

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
871
908
-4.05%
955
995
-3.99%
1 024
994
3.05%
1 176
1 038
13.29%
1 077
990
8.81%
892
850
4.85%
1 162
1 132
2.56%
1 179
1 136
3.76%
1 148
1 199
-4.3%

1 184


1 219


1 248


1 280


1 381

Net income
Million USD
Released
Forecast
Spread
770
720
7%
762
801
-4.8%
811
799
1.47%
931
820
13.42%
819
779
5.08%
700
677
3.43%
916
895
2.29%
1 035
909
13.87%
969
952
1.74%

946


971


989


1 003


1 091

EPS
USD
Released
Forecast
Spread
3,00
2,76
8.61%
2,96
3,14
-5.62%
3,13
3,07
1.98%
3,59
3,27
9.92%
3,15
3,09
1.86%
2,69
2,67
0.78%
3,52
3,43
2.58%
3,97
3,48
14.23%
3,71
3,57
4.04%

3,69


3,76


3,82


3,92


4,12

Announcement Date26/01/2205/05/2204/08/2227/10/2207/02/2301/05/2301/08/2306/11/2305/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Vertex Pharmaceuticals Incorporated - Nasdaq
  4. Calendar Vertex Pharmaceuticals Incorporated